Cencora (COR) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Cencora · Health Care · ref. ETF XLV · 50 calls · price $330.11
What the company does: Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
📈 Cencora (COR) stock price
$330.11+3.8% over range
Oct 14, 25low $252.74 · high $374.75Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 12 analysts
📊 JPI status : Cencora has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 COR price target & analyst consensus — price $330
The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$430+30.3%
Median target · of 11 targets$350+6.0%
Lowest target · 1 firm of 11$285-13.7%
Current price$330.11
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
982%
$339 ↔ $430
Below
218%
$285 ↔ $330
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (830 calls tested). It aims for $346 (+4.8 %), call made on August 8, 2026, maturing on August 8, 2027 (67 d ago).
The 6 reliable analysts
$389+18 %
The 5 other firms
$339+2.7 %
How to read it: the 6 reliable firms are not filtered by optimism — 6 aim above the price, 0 below, hence their $389 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 12 ratings (last 6 months)
Strong Buy00%
Buy975%
Hold325%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 COR price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on COR most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in COR? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Cencora? The JPI assistant answers using our backtest data.
💰 Cencora dividend: yield, history & growth › open the full page
0.81%annual yield
That's ~$2.35 per share per year.
📈 Cencora fundamentals: valuation, margins & growth › open the full page
P/E 24.1Net margin 0.8 %Revenue growth +5.1 %Fairly valued
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 1 %
2023
Rev +10%Profit +3%
2024
Rev +12%Profit −14%
2025
Rev +9%Profit +3%
🏛️ Cencora insider buying: who's buying and how much › open the full page
2 insiders bought3 buys / 6 mo $2.3M👥 Cluster buy
🔎 Detailed analyses
🏛️ Which US Congress members hold Cencora (COR)?
2 Congress members have disclosed COR buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Jared Moskowitz 2× · 25%Greg Landsman 1×
✅ Historical analyst reliability on COR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Evercore ISI Group ↗ | 100% | +46.1% | 2 |
| JP Morgan ↗ | 100% | +30.6% | 2 |
| Barclays ↗ | 100% | +26.8% | 2 |
| UBS ↗ | 100% | +26.0% | 2 |
| Leerink Partners ↗ | 100% | +19.1% | 2 |
| Baird ↗ | 80% | +24.3% | 5 |
| Citigroup ↗ | 50% | +9.2% | 2 |
| Wells Fargo ↗ | 50% | -1.5% | 2 |
📊 What $1,000 invested in Cencora would be worth › open the full page
In short — $1,000 invested in Cencora 10 years ago would be worth $2,729 today, i.e. +11%/yr on average. Best year: 2025 (+50%), worst: 2016 (-25%). Price performance, excluding dividends.
If I'd invested $1,000 in Cencora
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,259 | +26% |
| 3 years ago | $1,708 | +71% |
| 5 years ago | $2,895 | +189% |
Return by year (Cencora)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -16% | $838 (-16%) |
| 2025 | +50% | $1,259 (+26%) |
| 2024 | +9% | $1,378 (+38%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Cencora
Loading news…
📋 All analyst calls on COR
Filtered on — · ✕ show all
Leerink Partners ↗
Oct 7, 26
▲ Outperform · 🎯$388
Price at call : $321.35 — upside +21%
Today : $330.11 — upside +18%
🎯 on COR : no call matured yet · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
RBC Capital ↗
Sep 8, 26
■ Sector Perform neutral · not a buy · 🎯$330
Price at call : $323.32 — gap to target +2%
Today : $330.11 — gap to target -0%
🎯 on COR : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Sep 8, 27
matures : Sep 8, 27
RBC Capital ↗
Aug 19, 26
■ Sector Perform neutral · not a buy · 🎯$330
Price at call : $314.69 — gap to target +5%
Today : $330.11 — gap to target -0%
🎯 on COR : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
Wells Fargo ↗
Aug 11, 26
▲ Overweight · 🎯$395
Price at call : $333.87 — upside +18%
Today : $330.11 — upside +20%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
Morgan Stanley ↗
Aug 7, 26
▲ Overweight · 🎯$346
Price at call : $325 — upside +6%
Today : $330.11 — upside +5%
🎯 on COR : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Overweight · 🎯$390
Price at call : $325 — upside +20%
Today : $330.11 — upside +18%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Buy · 🎯$430
Price at call : $320.46 — upside +34%
Today : $330.11 — upside +30%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Evercore ISI Group ↗
Aug 6, 26
▲ Outperform · 🎯$350
Price at call : $320.46 — upside +9%
Today : $330.11 — upside +6%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
See the other 42 calls, newest to oldest
B of A Securities ↗
Jun 24, 26
■ Neutral neutral · not a buy · 🎯$285
Price at call : $286.95 — gap to target -1%
Today : $330.11 — gap to target -14%
🎯 on COR : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
▲ Overweight · 🎯$350
Price at call : $281.48 — upside +24%
Today : $330.11 — upside +6%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jun 10, 27
matures : Jun 10, 27
Wells Fargo ↗
May 11, 26
▲ Overweight · 🎯$331
Price at call : $259.7 — upside +27%
Today : $330.11 — upside +0%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
▲ Buy · 🎯$412
Price at call : $261.08 — upside +58%
Today : $330.11 — upside +25%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Buy · 🎯$355
Price at call : $261.08 — upside +36%
Today : $330.11 — upside +8%
🎯 on COR : 0% (1 call matured) · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Evercore ISI Group ↗
May 7, 26
▲ Outperform · 🎯$300
Price at call : $261.08 — upside +15%
Today : $330.11 — upside -9%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Outperform · 🎯$339
Price at call : $255.66 — upside +33%
Today : $330.11 — upside +3%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
William Blair ↗
Apr 28, 26
■ Market Perform neutral · not a buy
🎯 on COR : no call matured yet · 📊 on Health : 64.3% · +7.1% (28 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$360
Price at call : $322.46 — upside +12%
Today : $330.11 — upside +9%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
▲ Overweight · 🎯$425
Price at call : $359.97 — upside +18%
Today : $330.11 — upside +29%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
▲ Overweight · 🎯$419
Price at call : $365.7 — upside +15%
Today : $330.11 — upside +27%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Wells Fargo ↗
Feb 10, 26
▲ Overweight · 🎯$429
Price at call : $360 — upside +19%
Today : $330.11 — upside +30%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Evercore ISI Group ↗
Feb 5, 26
▲ Outperform · 🎯$420
Price at call : $359.25 — upside +17%
Today : $330.11 — upside +27%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Morgan Stanley ↗
Jan 29, 26
▲ Overweight · 🎯$400
Price at call : $359.22 — upside +11%
Today : $330.11 — upside +21%
🎯 on COR : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jan 29, 27
matures : Jan 29, 27
▲ Buy · 🎯$440
Price at call : $352.47 — upside +25%
Today : $330.11 — upside +33%
🎯 on COR : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
B of A Securities ↗
Jan 5, 26
■ Neutral neutral · not a buy · 🎯$360
Price at call : $340.92 — gap to target +6%
Today : $330.11 — gap to target +9%
🎯 on COR : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
▲ Overweight · 🎯$400
Price at call : $340.79 — upside +17%
Today : $330.11 — upside +21%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▲ Overweight · 🎯$417
Price at call : $363.42 — upside +15%
Today : $330.11 — upside +26%
🎯 on COR : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Nov 11, 26
matures : Nov 11, 26
Wells Fargo ↗
Nov 11, 25
▲ Overweight · 🎯$405
Price at call : $365.08 — upside +11%
Today : $330.11 — upside +23%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Nov 11, 26
matures : Nov 11, 26
▲ Buy · 🎯$400
Price at call : $365.08 — upside +10%
Today : $330.11 — upside +21%
🎯 on COR : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
▲ Buy · 🎯$415
Price at call : $364.65 — upside +14%
Today : $330.11 — upside +26%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Outperform · 🎯$395
Price at call : $360.7 — upside +10%
Today : $330.11 — upside +20%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Outperform · 🎯$380
Price at call : $360.24 — upside +5%
Today : $330.11 — upside +15%
🎯 on COR : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Outperform · 🎯$340
Price at call : $341.21 — upside -0%
Today : $330.11 — upside +3%
🎯 on COR : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
▲ Buy · 🎯$380
Price at call : $335.64 — upside +13%
Today : $330.11 — upside +15%
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
▲ Outperform · 🎯$334
Price at call : $319.4 — upside +5%
Today : $330.11 — upside +1%
🎯 on COR : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Oct 16, 26
matures : Oct 16, 26
Wells Fargo ↗
Aug 13, 25
▲ Overweight · 🎯$354
Price at call : $291.04 — upside +22%
Today : $330.11 — upside +7%
Expected +22% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
+6.5%
stock +7% · XLV +26%
matured Aug 13, 26
Morgan Stanley ↗
Jul 16, 25
■ Equal-Weight neutral · not a buy · 🎯$330
Price at call : $297.83 — gap to target +11%
Today : $330.11 — gap to target -0%
🎯 on COR : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jul 16, 26
matures : Jul 16, 26
■ Hold neutral · not a buy · 🎯$300
Price at call : $295.33 — gap to target +2%
Today : $330.11 — gap to target -9%
🎯 on COR : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Jun 30, 26
matures : Jun 30, 26
Wells Fargo ↗
Jun 3, 25
▲ Overweight · 🎯$337
Price at call : $291.55 — upside +16%
Today : $330.11 — upside +2%
Expected +16% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
-9.6%
stock -10% · XLV +11%
matured Jun 3, 26
▲ Buy · 🎯$355
Price at call : $283 — upside +25%
Today : $330.11 — upside +8%
Expected +25% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on COR : 0% (1 call matured) · 📊 on Health : 53.1% · +2.4% (516 calls)
-8.2%
stock -8% · XLV +8%
matured May 8, 26
▲ Outperform · 🎯$350
Price at call : $283.77 — upside +23%
Today : $330.11 — upside +6%
Expected +23% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-8.0%
stock -8% · XLV +7%
matured May 8, 26
▲ Buy · 🎯$335
Price at call : $292.67 — upside +14%
Today : $330.11 — upside +1%
Expected +14% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+5.2%
stock +5% · XLV +4%
matured Apr 29, 26
B of A Securities ↗
Apr 11, 25
■ Neutral neutral · not a buy · 🎯$285
Price at call : $284.33 — gap to target +0%
Today : $330.11 — gap to target -14%
🎯 on COR : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Apr 11, 26
matures : Apr 11, 26
Wells Fargo ↗
Mar 14, 25
■ Equal-Weight neutral · not a buy · 🎯$274
Price at call : $260.96 — gap to target +5%
Today : $330.11 — gap to target -17%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Mar 14, 26
matures : Mar 14, 26
Evercore ISI Group ↗
Feb 6, 25
▲ Outperform · 🎯$280
Price at call : $247.88 — upside +13%
Today : $330.11 — upside -15%
Expected +13% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
+46.6%
stock +47% · XLV +7%
matured Feb 6, 26
Wells Fargo ↗
Jan 29, 25
■ Equal-Weight neutral · not a buy · 🎯$251
Price at call : $255.94 — gap to target -2%
Today : $330.11 — gap to target -24%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jan 29, 26
matures : Jan 29, 26
▲ Overweight · 🎯$301
Price at call : $254.89 — upside +18%
Today : $330.11 — upside -9%
Expected +18% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
+39.5%
stock +39% · XLV +7%
matured Jan 24, 26
Wells Fargo ↗
Dec 13, 24
■ Equal-Weight neutral · not a buy · 🎯$237
Price at call : $229.82 — gap to target +3%
Today : $330.11 — gap to target -28%
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Dec 13, 25
matures : Dec 13, 25
▲ Outperform · 🎯$292
Price at call : $248.41 — upside +18%
Today : $330.11 — upside -12%
Expected +18% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 50% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+46.8%
stock +47% · XLV -2%
matured Nov 7, 25
▲ Buy · 🎯$285
Price at call : $248.41 — upside +15%
Today : $330.11 — upside -14%
Expected +15% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on COR : 100% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
+46.8%
stock +47% · XLV -2%
matured Nov 7, 25
Frequently asked questions
Should I buy Cencora stock?
This isn't buy advice. For Cencora, the analyst consensus is "Buy", with an average price target of $350 (+6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Cencora). We show the numbers — you decide.
Is it too late to buy Cencora? How high can it go?
The most bullish analyst target on Cencora is $430 (+30% above today's price); the average is $350. That's the upside they see. Check how reliable those analysts have actually been on Cencora on our site before trusting it.
Is Cencora still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 8 analysts have a real record on Cencora, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Cencora? The case for and against
The arguments for and against, one by one, from the numbers: why invest in COR (and why hesitate).
What has Cencora's past performance been?
Historical returns and a "how much if I had invested" calculator: COR performance & returns.
Does Cencora pay a dividend?
Yield, consistency and growth history of the dividend: COR's dividend.
Are insiders buying COR stock?
Executives' and large holders' buys and sells, decoded: insider buying on COR.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX